Table 1

Patient characteristics and associations between patient and tumour characteristics and surgery use in patients with non-small cell lung cancer, 1995–2006

All patientsPatients treated by surgery% treated with surgeryUnadjusted ORLower 95% CIUpper 95% CIp ValueAdjusted ORLower 95% CIUpper 95% CIp Value
All patients18 813237412.6%
 Men12 308156712.7%
 Women650580712.4%0.970.891.060.5220.950.861.040.249
Age group linear trend*0.660.630.69<0.0010.660.630.69<0.001
 <60316553016.8%
 60–69521587516.8%1.000.891.131.000.891.13
 70–79748688211.8%0.660.590.750.660.590.75
 ≥802947873.0%0.150.120.190.150.120.19
Diagnosis period linear trend*0.910.880.95<0.0010.950.920.990.022
 1995–1997446164714.5%
 1998–2000462957412.4%0.830.740.940.870.770.98
 2001–2003484761712.7%0.860.760.970.950.851.08
 2004–2006487653611.0%0.730.640.820.850.750.97
Other non-small cell36982526.8%
Adenocarcinoma549089616.3%2.672.303.09<0.0012.582.233.00<0.001
Squamous cell9625122612.7%2.001.732.30<0.0012.081.802.41<0.001
Deprivation linear trend*0.950.920.990.0090.960.930.990.018
 Most affluent353148013.6%
 2425654012.7%0.920.811.050.950.831.09
 3482961912.8%0.930.821.060.950.831.08
 4438453712.3%0.890.781.010.900.791.03
 Most deprived181319810.9%0.780.650.930.780.650.94
  • * Entered as a continuous variable.

  • OR: Odds Ratio CI: Confidence Interval

  • Italics denote such ‘test for linear trend’ variables.